Christopher R. Cline insider trades
Open-market stock purchases and sales by Christopher R. Cline, CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc, from SEC Form 4 filings since Sep 1, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $121K |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $26.1K |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $1.7M |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $1.3M |
| Sep 2, 2026 | TVTX Travere Therapeutics, Inc | Sold | $42.6K |
| May 6, 2026 | TVTX Travere Therapeutics, Inc | Sold | $13.6K |
| May 5, 2026 | TVTX Travere Therapeutics, Inc | Sold | $102K |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 4, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $43.2K |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Sold | $370 |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Sold | $304K |
| Apr 13, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 13, 2026 | TVTX Travere Therapeutics, Inc | Sold | $1.9K |
| Feb 4, 2026 | TVTX Travere Therapeutics, Inc | Sold | $52.5K |
| Feb 4, 2026 | TVTX Travere Therapeutics, Inc | Sold | $3.6K |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc | Sold | $233K |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Dec 1, 2025 | TVTX Travere Therapeutics, Inc | Sold | $700K |
| Dec 1, 2025 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TVTX Travere Therapeutics, Inc: 32 sales, last Sep 15, 2026
Get free alerts when Christopher R. Cline files a new trade →